Mindray's COVID-19 antigen reagent was approved by NMPA

On July 10, 2023, NMPA released information on the delivery of medical device approval certification documents.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. has been certified for its new coronavirus (2019-nCoV) antigen detection kit (colloidal gold method), National Instruments Note Approval 20233400920.

Although many companies have terminated the registration in the first half of the year, Mindray resolutely pushed forward the registration and got the license.

At the moment there are still a lot of second positive infections sporadic occurrences, a few days ago Chow Yun-Fat diagnosis of suspension of rest once again triggered people's attention, the antigen reagent still exists in a small portion of the demand.

Mindray previously had a cooperation with Jingshuo to promote the COVID-19 antigen. This time the license, the market harvest is certainly not big, after all, there have been more than 50 licensed, the market has long been oversupplied. But it also reflects the execution of the enterprise.